Crossref
ICH S12: nonclinical biodistribution considerations for gene therapy products
The Biomedical & Life Sciences Collection · 30.09.2026 · 2026 (9) · e1012127
DOI: 10.69645/cuyc7820 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Biomedical & Life Sciences Collection, online erschienen am 30.09.2026. Verfasst von Tineke van den Hoorn. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hoorn, T. V. D. (2026). ICH S12: nonclinical biodistribution considerations for gene therapy products. The Biomedical & Life Sciences Collection, 2026(9), e1012127. https://doi.org/10.69645/cuyc7820
Vancouver
Hoorn TVD. ICH S12: nonclinical biodistribution considerations for gene therapy products. The Biomedical & Life Sciences Collection. 2026;2026(9):e1012127. doi:10.69645/cuyc7820
BibTeX
@article{Hoorn2026,
author = {Hoorn, Tineke van den},
title = {ICH S12: nonclinical biodistribution considerations for gene therapy products},
journal = {The Biomedical & Life Sciences Collection},
year = {2026},
volume = {2026},
number = {9},
pages = {e1012127},
doi = {10.69645/cuyc7820}
}
EUVIMED